Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Antcliffe DB"'
Publikováno v:
Infection and Drug Resistance, Vol Volume 16, Pp 2709-2726 (2023)
Timothy M Rawson,1– 3 David B Antcliffe,2,4 Richard C Wilson,1– 3 Alireza Abdolrasouli,5 Luke SP Moore1,6,7 1Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Hammersmith Hospital, London, UK; 2Cent
Externí odkaz:
https://doaj.org/article/95ac32d334eb46f2b0ad2d7ff2af139c
Autor:
Mi Y; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK., Burnham KL; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK., Charles PD; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK., Heilig R; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK., Vendrell I; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford OX3 7BN, UK., Whalley J; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK., Torrance HD; Division of Anaesthetics, Pain Medicine and Intensive Care, Imperial College, London SW7 2AZ, UK., Antcliffe DB; Division of Anaesthetics, Pain Medicine and Intensive Care, Imperial College, London SW7 2AZ, UK.; Department of Critical Care, Imperial College Healthcare NHS Trust, London W2 1NY, UK., May SM; Translational Medicine and Therapeutics, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK., Neville MJ; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LE, UK.; NIHR Oxford Biomedical Research Centre, Oxford OX3 9DU, UK., Berridge G; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK., Hutton P; Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7JX, UK., Geoghegan CG; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK., Radhakrishnan J; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK., Nesvizhskii AI; Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA., Yu F; Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA., Davenport EE; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK., McKechnie S; Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7JX, UK., Davies R; Division of Anaesthetics, Pain Medicine and Intensive Care, Imperial College, London SW7 2AZ, UK., O'Callaghan DJP; Division of Anaesthetics, Pain Medicine and Intensive Care, Imperial College, London SW7 2AZ, UK.; Department of Critical Care, Imperial College Healthcare NHS Trust, London W2 1NY, UK., Patel P; Department of Critical Care, Imperial College Healthcare NHS Trust, London W2 1NY, UK., Del Arroyo AG; Translational Medicine and Therapeutics, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK., Karpe F; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LE, UK.; NIHR Oxford Biomedical Research Centre, Oxford OX3 9DU, UK., Gordon AC; Division of Anaesthetics, Pain Medicine and Intensive Care, Imperial College, London SW7 2AZ, UK.; Department of Critical Care, Imperial College Healthcare NHS Trust, London W2 1NY, UK., Ackland GL; Translational Medicine and Therapeutics, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK., Hinds CJ; Translational Medicine and Therapeutics, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK., Fischer R; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford OX3 7BN, UK., Knight JC; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford OX3 7BN, UK.; NIHR Oxford Biomedical Research Centre, Oxford OX3 9DU, UK.
Publikováno v:
Science translational medicine [Sci Transl Med] 2024 Jun 05; Vol. 16 (750), pp. eadh0185. Date of Electronic Publication: 2024 Jun 05.
Autor:
Antcliffe DB; Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK d.antcliffe@imperial.ac.uk.; Centre for Perioperative and Critical Care Research, Imperial College Healthcare NHS Trust, London, UK., Mi Y; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Santhakumaran S; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, London, UK., Burnham KL; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Prevost AT; Nightingale-Saunders Clinical Trials and Epidemiology Unit, King's College London, London, UK., Ward JK; Conway Institute, School of Medicine, University College Dublin, Dublin, Ireland., Marshall TJ; Department of Anaesthetics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.; Central Clinical School Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Bradley C; Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK., Al-Beidh F; Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK., Hutton P; Adult Intensive Care Unit, John Radcliffe Hospital, Oxford, UK., McKechnie S; Adult Intensive Care Unit, John Radcliffe Hospital, Oxford, UK., Davenport EE; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Hinds CJ; William Harvey Research Institute, Barts & The London School of Medicine and Dentistry, Queen Mary University of London, London, UK., O'Kane CM; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK., McAuley DF; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.; Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, UK.; Northern Ireland Clinical Trials Unit, Royal Hospitals, Belfast, UK., Shankar-Hari M; The Queen's Medical Research Institute, The University of Edinburgh College of Medicine and Veterinary Medicine, Edinburgh, UK.; Intensive Care Unit, Royal Infirmary of Edinburgh, Edinburgh, UK., Gordon AC; Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Centre for Perioperative and Critical Care Research, Imperial College Healthcare NHS Trust, London, UK., Knight JC; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK.
Publikováno v:
Thorax [Thorax] 2024 May 20; Vol. 79 (6), pp. 515-523. Date of Electronic Publication: 2024 May 20.
Autor:
Woodbridge HR; Imperial College Healthcare NHS Trust, London, UK. h.woodbridge@imperial.ac.uk.; Department of Surgery and Cancer, Imperial College London, London, UK. h.woodbridge@imperial.ac.uk., McCarthy CJ; Manchester Metropolitan University, Manchester, UK., Jones M; Brunel University London, London, UK., Willis M; Imperial College Healthcare NHS Trust, London, UK., Antcliffe DB; Imperial College Healthcare NHS Trust, London, UK.; Department of Surgery and Cancer, Imperial College London, London, UK., Alexander CM; Imperial College Healthcare NHS Trust, London, UK.; Department of Surgery and Cancer, Imperial College London, London, UK., Gordon AC; Imperial College Healthcare NHS Trust, London, UK.; Department of Surgery and Cancer, Imperial College London, London, UK.
Publikováno v:
Critical care (London, England) [Crit Care] 2024 Apr 30; Vol. 28 (1), pp. 144. Date of Electronic Publication: 2024 Apr 30.
Autor:
Kherabi Y; Infectious and Tropical Disease Department, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France; Université Paris Cité and Université Sorbonne Paris Nord, Inserm, IAME, Paris, France. Electronic address: yousra.kherabi@aphp.fr., Thy M; Medical and Infectious Diseases ICU (MI2) - Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France; EA 7323 - Pharmacology and Therapeutic Evaluation in Children and Pregnant Women, Université Paris Cité, Paris, France., Bouzid D; Université Paris Cité and Université Sorbonne Paris Nord, Inserm, IAME, Paris, France; Emergency Department, Bichat Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France., Antcliffe DB; Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London, London, UK; Department of Intensive Care Unit, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Rawson TM; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; Centre for Antimicrobial Optimisation Imperial College London, London, UK., Peiffer-Smadja N; Infectious and Tropical Disease Department, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France; Université Paris Cité and Université Sorbonne Paris Nord, Inserm, IAME, Paris, France; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK.
Publikováno v:
Infectious diseases now [Infect Dis Now] 2024 Apr; Vol. 54 (3), pp. 104864. Date of Electronic Publication: 2024 Feb 12.
A Transcriptomic Approach to Understand Patient Susceptibility to Pneumonia After Abdominal Surgery.
Autor:
Torrance HD; Division of Anaesthetics, Pain Medicine & Intensive Care Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London. UK., Zhang P; Wellcome Centre for Human Genetics, University of Oxford, Oxford. UK.; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK., Longbottom ER; Centre for Translational Medicine & Therapeutics, William Harvey Institute, Faculty of Medicine & Dentistry at Queen Mary University of London, London. UK., Mi Y; Wellcome Centre for Human Genetics, University of Oxford, Oxford. UK., Whalley JP; Wellcome Centre for Human Genetics, University of Oxford, Oxford. UK.; Center for Cancer Cell Biology, Immunology, and Infection, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL., Allcock A; Wellcome Centre for Human Genetics, University of Oxford, Oxford. UK., Kwok AJ; Wellcome Centre for Human Genetics, University of Oxford, Oxford. UK., Cano-Gamez E; Wellcome Centre for Human Genetics, University of Oxford, Oxford. UK., Geoghegan CG; Wellcome Centre for Human Genetics, University of Oxford, Oxford. UK., Burnham KL; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK., Antcliffe DB; Division of Anaesthetics, Pain Medicine & Intensive Care Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London. UK., Davenport EE; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK., Pearse RM; Centre for Translational Medicine & Therapeutics, William Harvey Institute, Faculty of Medicine & Dentistry at Queen Mary University of London, London. UK., O'Dwyer MJ; Department of Anaesthesia and Critical Care, St Vincent's University Hospital, Dublin. Ireland., Hinds CJ; Centre for Translational Medicine & Therapeutics, William Harvey Institute, Faculty of Medicine & Dentistry at Queen Mary University of London, London. UK., Knight JC; Wellcome Centre for Human Genetics, University of Oxford, Oxford. UK.; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK., Gordon AC; Division of Anaesthetics, Pain Medicine & Intensive Care Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London. UK.
Publikováno v:
Annals of surgery [Ann Surg] 2024 Mar 01; Vol. 279 (3), pp. 510-520. Date of Electronic Publication: 2023 Jul 27.
Autor:
Nelmes E; Imperial College London, London, UK enelmes@ic.ac.uk., Edwards L; Royal Marsden NHS Foundation Trust, London, UK., Jhanji S; Royal Marsden NHS Foundation Trust, London, UK., Antcliffe DB; Imperial College London, London, UK., Tatham KC; Imperial College London, London, UK and Consultant in Critical Care and Anaesthesia, Royal Marsden NHS Foundation Trust, London, UK.
Publikováno v:
Clinical medicine (London, England) [Clin Med (Lond)] 2023 Dec 08; Vol. 23 (6), pp. 635-636. Date of Electronic Publication: 2023 Dec 08.
Autor:
Warner BE; Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London, London, UK.; Department of Critical Care Medicine, Imperial College Healthcare NHS Trust, London, UK., Harry A; Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London, London, UK.; Department of Anaesthetics, Royal Free London NHS Foundation Trust, London, UK., Wells M; Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London, London, UK.; Department of Surgery and Cancer, Imperial College London, London, UK., Brett SJ; Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London, London, UK.; Department of Critical Care Medicine, Imperial College Healthcare NHS Trust, London, UK., Antcliffe DB; Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London, London, UK.; Department of Critical Care Medicine, Imperial College Healthcare NHS Trust, London, UK.
Publikováno v:
Age and ageing [Age Ageing] 2023 Apr 01; Vol. 52 (4).
Autor:
Cleasby C; Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK., Marshall T; Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Department of Anaesthetics, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Gordon AC; Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK., Antcliffe DB; Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK. d.antcliffe@imperial.ac.uk.
Publikováno v:
Intensive care medicine [Intensive Care Med] 2023 Feb; Vol. 49 (2), pp. 241-243. Date of Electronic Publication: 2023 Jan 11.